IPSC (STOCKS)
Century Therapeutics, Inc. Common Stock
$1.830000
-0.100000 (-5.18%)
Prev close: $1.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Brent Pfeiffenberger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $178.62M
- Employees
- 165
- P/E (TTM)
- -5.76
- P/B (TTM)
- 0.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $113.34M |
| Benefits Costs and Expenses | $138.04M |
| Costs And Expenses | $138.04M |
| Nonoperating Income/Loss | $9.20M |
| Operating Expenses | $147.23M |
| Operating Income/Loss | -$33.90M |
| Income/Loss From Continuing Operations After Tax | -$26.48M |
| Income/Loss From Continuing Operations Before Tax | -$24.71M |
| Net Income/Loss | -$26.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.32 |
| Diluted Earnings Per Share | -$0.32 |
| Basic Average Shares | 260,978,030 |
| Diluted Average Shares | 261,055,461 |
| Assets | $244.72M |
| Current Assets | $137.71M |
| Noncurrent Assets | $107.01M |
| Fixed Assets | $53.72M |
| Intangible Assets | $34.20M |
| Other Non-current Assets | $19.09M |
| Liabilities | $68.37M |
| Current Liabilities | $22.03M |
| Accounts Payable | $2.62M |
| Wages | $3.54M |
| Other Current Liabilities | $15.87M |
| Noncurrent Liabilities | $46.34M |
| Equity | $176.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $176.35M |
| Liabilities And Equity | $244.72M |
| Net Cash Flow From Operating Activities | -$112.02M |
| Net Cash Flow From Operating Activities, Continuing | -$112.02M |
| Net Cash Flow From Investing Activities | $115.75M |
| Net Cash Flow From Investing Activities, Continuing | $115.75M |
| Net Cash Flow From Financing Activities | -$482.00K |
| Net Cash Flow From Financing Activities, Continuing | -$482.00K |
| Net Cash Flow | $3.24M |
| Net Cash Flow, Continuing | $3.24M |
| Comprehensive Income/Loss | -$27.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$27.18M |
| Other Comprehensive Income/Loss | -$694.00K |